Under Attack

Posted on 2 Jun 2017

We are very pleased to announce that ME Research UK has awarded a research grant to Dr Madlen Löbel and Prof. Carmen Scheibenbogen at the Institute of Medical Immunology in Berlin. Following on from their findings that levels of autoantibodies against adrenergic receptors are increased in some people with ME/CFS, the researchers plan to explore the potential links between these autoantibodies and some of the symptoms and immune system...

Read More

ME Research UK and the UK ME/CFS Research Collaborative

Posted on 19 May 2017

ME Research UK has taken the decision to withdraw its membership from the UK CFS/ME Research Collaborative with immediate effect. ME Research UK exists to fund biomedical research into ME/CFS, to find its cause, to develop effective treatments and ultimately to discover a cure. In 17 years, it has funded 45 specific research projects in the UK and overseas, more than any other single organisation in the world outside the American continent. The...

Read More

Experiences of post-infectious fatigue syndrome

Posted on 17 Apr 2017

As scientists, it is very easy for us to focus on the biological details of an illness like ME/CFS and forget about the patients themselves. Hence the value of studies such as that by Eva Stormorken at the University of Oslo and Prof. Leonard Jason at DePaul University in Chicago, who in 2015 looked at the experiences of patients with post-infectious fatigue syndrome (PIFS). PIFS can be considered a subtype of ME/CFS where symptoms develop...

Read More

CMRC Minutes March 2017

Posted on 10 Apr 2017

The UK ME/CFS Research Collaborative (CMRC) held a board meeting on 21st March 2017 to discuss relevant issues, such as plans for an autumn 2017 conference, MEGA study and research matters. The draft Minutes are provided below. Launched in 2013 (see our overview of the event), the aim of the CMRC is to promote the highest quality of basic and applied evidenced-based and peer reviewed research into ME/CFS by bringing together national agencies,...

Read More

Signature Move

Posted on 5 Apr 2017

We are delighted to announce that ME Research UK has awarded a new research grant to Prof. David Patrick at the University of British Columbia. As a new randomised trial in Norway investigates the potential of rituximab as a treatment for ME/CFS, Prof. Patrick and his team plan to use samples from that trial in developing an immunosignature to identify those patients most likely to benefit from the drug. This is important because rituximab is...

Read More

Pin It on Pinterest